human | Q5 |
P734 | family name | Farquhar | Q1397056 |
Farquhar | Q1397056 | ||
Farquhar | Q1397056 | ||
P735 | given name | Carey | Q20706333 |
Carey | Q20706333 | ||
P106 | occupation | researcher | Q1650915 |
Q90028613 | A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection |
Q36912247 | A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women |
Q92668909 | Analysis of the TCR Repertoire in HIV-Exposed but Uninfected Infants |
Q36062914 | Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission |
Q28270788 | Antiretroviral prophylaxis for HIV prevention in heterosexual men and women |
Q46914878 | Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens |
Q92012665 | Assisted HIV partner services training in three sub-Saharan African countries: facilitators and barriers to sustainable approaches |
Q47601085 | Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya |
Q92012954 | Assisted partner notification services for patients receiving HIV care and treatment in an HIV clinic in Nairobi, Kenya: a qualitative assessment of barriers and opportunities for scale-up |
Q28649360 | Assisted partner notification services to augment HIV testing and linkage to care in Kenya: study protocol for a cluster randomized trial |
Q40425900 | Assisted partner services for HIV in Kenya: a cluster randomised controlled trial |
Q35452737 | Barriers to antiretroviral initiation in HIV-1-discordant couples. |
Q36836852 | Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission |
Q92926064 | Birth size and early pneumonia predict linear growth among HIV-exposed uninfected infants |
Q35463763 | Breast milk HIV-1 RNA levels and female sex are associated with HIV-1-specific CD8+ T-cell responses in HIV-1-exposed, uninfected infants in Kenya |
Q36055623 | Breast milk alpha-defensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission |
Q37032208 | Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission |
Q36662412 | Building capacity in implementation science research training at the University of Nairobi |
Q35979691 | C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya |
Q81405710 | CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmission |
Q37320759 | CCR2-64I polymorphism is associated with lower maternal HIV-1 viral load and reduced vertical HIV-1 transmission |
Q37237797 | Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples |
Q33436735 | Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study |
Q28744206 | Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention |
Q36023751 | Cofactors for HIV-1 incidence during pregnancy and postpartum period |
Q37378355 | Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women |
Q93162011 | Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission |
Q37528411 | Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection |
Q46306056 | Condom use among sexually active Kenyan female adolescents at risk for HIV-1 infection |
Q35852451 | Consistency of Mycobacterium tuberculosis-specific interferon-gamma responses in HIV-1-infected women during pregnancy and postpartum |
Q45905749 | Correction: Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure. |
Q35084426 | Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants |
Q37396579 | Cost effectiveness of couple counselling to enhance infant HIV-1 prevention |
Q33881449 | Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial |
Q33831463 | Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships |
Q36469327 | Delayed initiation of antiretroviral therapy among HIV-discordant couples in Kenya |
Q35582308 | Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women |
Q34030252 | Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples |
Q34398967 | Distance from home to study clinic and risk of follow-up interruption in a cohort of HIV-1-discordant couples in Nairobi, Kenya |
Q36062923 | Domestic violence and prevention of mother-to-child transmission of HIV-1. |
Q40796473 | Dual contraceptive method use in HIV-serodiscordant Kenyan couples |
Q36048997 | Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children |
Q28728582 | Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2 |
Q93129147 | Epidemiology of adult meningitis during antiretroviral therapy scale-up in southern Africa: Results from the Botswana national meningitis survey |
Q33932523 | Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections |
Q33697958 | Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk |
Q53698238 | Ethical Obligations in Short-Term Global Health Clinical Experiences: The Devil Is in the Details. |
Q64895260 | Evaluating Academic Mentorship Programs in Low- and Middle-Income Country Institutions: Proposed Framework and Metrics |
Q34284091 | Expanding clinical medical training opportunities at the University of Nairobi: adapting a regional medical education model from the WWAMI program at the University of Washington |
Q53683269 | Facilitators, context of and barriers to acute coronary syndrome care at Kenyatta National Hospital, Nairobi, Kenya: a qualitative analysis. |
Q35146408 | Frequency and correlates of malaria over-treatment in areas of differing malaria transmission: a cross-sectional study in rural Western Kenya |
Q33553821 | Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices |
Q29417004 | Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure |
Q28551019 | Global health leadership training in resource-limited settings: a collaborative approach by academic institutions and local health care programs in Uganda |
Q53401372 | HIV Self-Testing Increases HIV Testing Frequency in High Risk Men Who Have Sex with Men: A Randomized Controlled Trial. |
Q58733255 | HIV partner services in Kenya: a cost and budget impact analysis study |
Q36088972 | HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality |
Q36879257 | HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy |
Q36378669 | HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls |
Q58756839 | HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort |
Q28731648 | HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships |
Q33936741 | HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission |
Q35912177 | Health care-seeking behaviour of HIV-infected mothers and male partners in Nairobi, Kenya |
Q33908206 | Health facility factors and quality of services to prevent mother-to-child HIV transmission in Côte d'Ivoire, Kenya, and Mozambique |
Q45407660 | Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission |
Q34508433 | Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons |
Q33921326 | Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women |
Q30724659 | High Rates of Exclusive Breastfeeding in Both Arms of a Peer Counseling Study Promoting EBF Among HIV-Infected Kenyan Women |
Q89426728 | High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi |
Q36055407 | High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody |
Q37694118 | High rates of relationship dissolution among heterosexual HIV-serodiscordant couples in Kenya |
Q36069338 | High uptake of postpartum hormonal contraception among HIV-1-seropositive women in Kenya |
Q40073325 | Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine |
Q60046600 | Higher prevalence of viral control in HIV-1-infected women in serodiscordant relationships |
Q48511329 | Hiv Assisted Partner Services Among Those with and Without A History of Intimate Partner Violence in Kenya |
Q28649558 | Home visits during pregnancy enhance male partner HIV counselling and testing in Kenya: a randomized clinical trial |
Q28595605 | Home-Based HIV Testing Among Pregnant Couples Increases Partner Testing and Identification of Serodiscordant Partnerships |
Q28645985 | Home-based HIV testing for men preferred over clinic-based testing by pregnant women and their male partners, a nested cross-sectional study |
Q36049028 | Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women |
Q90122969 | Hospital-Based Quality Improvement Interventions for Patients With Acute Coronary Syndrome: A Systematic Review |
Q35115540 | Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa |
Q36049157 | Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission |
Q92526734 | Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya |
Q37459448 | Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmission |
Q36509801 | Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya |
Q37425515 | Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination |
Q96130115 | Impact of the COVID-19 Pandemic on HIV Testing and Assisted Partner Notification Services, Western Kenya |
Q37014059 | Implementation and Operational Research: Impact of a Systems Engineering Intervention on PMTCT Service Delivery in Côte d'Ivoire, Kenya, Mozambique: A Cluster Randomized Trial |
Q64237466 | Implementation and evaluation of an innovative leadership and teacher training program for non-physician emergency medicine practitioners in Uganda |
Q37145745 | Incident HSV-2 infections are common among HIV-1-discordant couples |
Q92012647 | Index participant characteristics and HIV assisted partner services efficacy in Kenya: results of a cluster randomized trial |
Q37669547 | Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships |
Q28730640 | Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial |
Q94150751 | Influences of Exclusive Breastfeeding Among Low-wage, Working Mothers in Kenya: Perspectives from Managers, Healthcare Providers, Daycare Directors, Mothers, and Fathers (OR30-02-19) |
Q88676441 | Integrated HIV-injury programming: an underutilized intersection to engage young adults in HIV care in low and middle-income countries |
Q36806473 | Interprofessional Fellowship Training for Emerging Global Health Leaders in Africa to Improve HIV Prevention and Care: The Afya Bora Consortium |
Q35158962 | Kenyan medical student and consultant experiences in a pilot decentralized training program at the University of Nairobi |
Q42626815 | Kenyan women medical doctors and their motivations to pursue international research training |
Q28727315 | Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya |
Q34678691 | Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children |
Q37741693 | Lay beliefs about hypertension among HIV-infected adults in Kenya |
Q33610797 | Linkage to HIV care and antiretroviral therapy by HIV testing service type in Central Mozambique: a retrospective cohort study |
Q36673503 | Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy |
Q33843438 | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants |
Q36054956 | Longitudinal comparison of chemokines in breastmilk early postpartum among HIV-1-infected and uninfected Kenyan women |
Q40137739 | Low Bacteremia Prevalence Among Febrile Children in Areas of Differing Malaria Transmission in Rural Kenya: A Cross-Sectional Study |
Q33785181 | Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya |
Q92012602 | Low risk of social harms in an HIV assisted partner services programme in Cameroon |
Q90904748 | Male Partner Linkage to Clinic-Based Services for Sexually Transmitted Infections and Human Immunodeficiency Virus Services Following Couple Home-Based Education and Testing |
Q40695551 | Male Partner Participation in Antenatal Clinic Services is Associated With Improved HIV-Free Survival Among Infants in Nairobi, Kenya: A Prospective Cohort Study |
Q34420652 | Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival |
Q33514433 | Male perspectives on incorporating men into antenatal HIV counseling and testing |
Q89889528 | Maternal Diarrhea and Antibiotic Use are Associated with Increased Risk of Diarrhea among HIV-Exposed, Uninfected Infants in Kenya |
Q37209882 | Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. |
Q36116252 | Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission |
Q35087763 | Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women |
Q34161077 | Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy |
Q37255631 | Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial |
Q88932330 | Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya |
Q34048397 | Mode of delivery and postpartum HIV-1 disease progression and mortality in a Kenyan cohort |
Q37420094 | Modeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya |
Q36023789 | Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up |
Q92764907 | Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis |
Q93097902 | Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study |
Q92445330 | Mycoplasma genitalium infection among HIV-infected pregnant African women and implications for mother-to-child transmission of HIV |
Q36509600 | Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters |
Q36055490 | Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya |
Q37379992 | Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality |
Q35570698 | Performance of clinical algorithms for HIV-1 diagnosis and antiretroviral initiation among HIV-1-exposed children aged less than 18 months in Kenya |
Q33961836 | Performance of the integrated management of childhood illness algorithm for diagnosis of HIV-1 infection among African infants |
Q93166910 | Postpartum metabolic syndrome after gestational hypertension and preeclampsia, a prospective cohort study |
Q34634872 | Predicting pregnancy in HIV-1-discordant couples |
Q36049003 | Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children |
Q30494934 | Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort |
Q36533709 | Pregnant women and disclosure to sexual partners after testing HIV-1-seropositive during antenatal care |
Q89021936 | Presentation, management and outcomes of acute coronary syndrome: a registry study from Kenyatta National Hospital in Nairobi, Kenya |
Q45707807 | Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women |
Q47950381 | Prevalence of HIV-Seropositivity and Associated Impact on Mortality among Injured Patients from Low-and Middle-Income Countries: A Systematic Review and Meta-Analysis |
Q36767208 | Prevalence, perceptions, and correlates of pediatric HIV disclosure in an HIV treatment program in Kenya |
Q94565096 | Psychosocial Factors, Condomless Sex, and Detectable Viral Load in HIV-Positive Women in Serodiscordant Couples in Nairobi, Kenya |
Q36253005 | Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1 |
Q95330944 | Reaching hard-to-reach men through home-based couple HIV testing among pregnant women and their male partners in western Kenya: a qualitative study |
Q39247079 | Right from primary school, I liked science: understanding health research capacity building in sub-Saharan Africa through Kenyan training experiences |
Q35570693 | Risk factors for neonatal conjunctivitis in babies of HIV-1 infected mothers |
Q58281958 | Role of male partners in the prevention of mother-to-child HIV transmission |
Q36055396 | Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk |
Q37543392 | Seroprevalence of measles IgG among HIV-1-infected and uninfected Kenyan adults |
Q33518566 | Sexually transmitted infections among HIV-1-discordant couples |
Q36509679 | Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir |
Q30858811 | Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
Q36250409 | Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries |
Q33992708 | Strengthening health systems by integrating health care, medical education, and research: University of Nairobi experience. |
Q35748468 | Supporting early career health investigators in Kenya: A qualitative study of HIV/AIDS research capacity building |
Q28596036 | Surveillance of HIV assisted partner services using routine health information systems in Kenya |
Q38960642 | Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya |
Q33603838 | Systems analysis and improvement to optimize pMTCT (SAIA): a cluster randomized trial |
Q35126572 | The Afya Bora Consortium: an Africa-US partnership to train leaders in global health |
Q40116534 | The Afya Bora Fellowship: An Innovative Program Focused on Creating an Interprofessional Network of Leaders in Global Health |
Q30620881 | The Clinical Education Partnership Initiative: an innovative approach to global health education |
Q37040036 | The Stigma of Exclusive Breastfeeding Among Both HIV-Positive and HIV-Negative Women in Nairobi, Kenya |
Q37336986 | The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants |
Q35909803 | The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonization |
Q35825248 | The prevalence of stunting is high in HIV-1-exposed uninfected infants in Kenya |
Q35753522 | The role of G protein gene GNB3 C825T polymorphism in HIV-1 acquisition, progression and immune activation |
Q40795217 | Training tomorrow's global health leaders: applying a transtheoretical model to identify behavior change stages within an intervention for health leadership development |
Q36137079 | Training tomorrow's leaders in global health: impact of the Afya Bora Consortium Fellowship on the careers of its alumni |
Q30217436 | Traumatic near amputation secondary to hippopotamus attack: lessons for surgeons |
Q39183964 | Understanding Barriers to Scaling Up HIV-Assisted Partner Services in Kenya |
Q37503472 | Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study |
Q40082634 | Uptake of Home-Based Syphilis and Human Immunodeficiency Virus Testing Among Male Partners of Pregnant Women in Western Kenya |
Q35856509 | Uptake of prevention of mother to child transmission interventions in Kenya: health systems are more influential than stigma |
Q38750431 | Using lean manufacturing principles to evaluate wait times for HIV-positive patients in an urban clinic in Kenya |
Q34515366 | Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission |
Q35669036 | Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial |
Q90313402 | Virological failure in children living with HIV on antiretroviral therapy: correlates and predictive value of clinical measurements and CD4 cell count |
Search more.